Study: NCT04225715

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nucleos(t)ide (NUC)
Description: Nucleos(t)ide (NUC) will be administered orally

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nucleos(t)ide (NUC)
Description: Nucleos(t)ide (NUC) will be administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nucleos(t)ide (NUC)
Description: Nucleos(t)ide (NUC) will be administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nucleos(t)ide (NUC)
Description: Nucleos(t)ide (NUC) will be administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nucleos(t)ide (NUC)
Description: Nucleos(t)ide (NUC) will be administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nucleos(t)ide (NUC)
Description: Nucleos(t)ide (NUC) will be administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nucleos(t)ide (NUC)
Description: Nucleos(t)ide (NUC) will be administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nucleos(t)ide (NUC)
Description: Nucleos(t)ide (NUC) will be administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nucleos(t)ide (NUC)
Description: Nucleos(t)ide (NUC) will be administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CpAM (RO7049389)
Description: CpAM (RO7049389) will be administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CpAM (RO7049389)
Description: CpAM (RO7049389) will be administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TLR7 (RO7020531)
Description: TLR7 (RO7020531) will be administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TLR7 (RO7020531)
Description: TLR7 (RO7020531) will be administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: siRNA (RO7445482)
Description: siRNA (RO7445482) will be administered subcutaneously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: siRNA (RO7445482)
Description: siRNA (RO7445482) will be administered subcutaneously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: siRNA (RO7445482)
Description: siRNA (RO7445482) will be administered subcutaneously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: siRNA (RO7445482)
Description: siRNA (RO7445482) will be administered subcutaneously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: siRNA (RO7445482)
Description: siRNA (RO7445482) will be administered subcutaneously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: siRNA (RO7445482)
Description: siRNA (RO7445482) will be administered subcutaneously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: siRNA (RO7445482)
Description: siRNA (RO7445482) will be administered subcutaneously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PEG-IFN
Description: PEG-IFN will be administered subcutaneously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PD-L1 LNA (RO7191863)
Description: PD-L1 LNA (RO7191863) will be administered subcutaneously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PD-L1 LNA (RO7191863)
Description: PD-L1 LNA (RO7191863) will be administered subcutaneously